Real-world clinical practice outcomes in hepatitis C-infected patients with psychiatric and substance use disorders treated with glecaprevir/pibrentasvir for 8 or 12 weeks: a pooled analysis across nine countries

Pietro Lampertico, Georges‐Philippe Pageaux, Nuno Marques et al.|Journal of Hepatology|2020

Cited by 2